85 related articles for article (PubMed ID: 17360185)
41. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma.
Sentani K; Tashiro T; Oue N; Yasui W
APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414
[No Abstract] [Full Text] [Related]
42. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
43. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Pfeiffer RM; Gadalla SM; Swain SM; Merajver SD; Brown LM; Soliman AS
Breast Cancer Res Treat; 2019 Jul; 176(2):407-417. PubMed ID: 31006821
[TBL] [Abstract][Full Text] [Related]
44. Basal cytokeratin expression in relation to biological factors in breast cancer.
Kuroda H; Ishida F; Nakai M; Ohnisi K; Itoyama S
Hum Pathol; 2008 Dec; 39(12):1744-50. PubMed ID: 18755493
[TBL] [Abstract][Full Text] [Related]
45. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
47. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
48. The prognostic importance of triple negative breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gülben K
Breast; 2008 Aug; 17(4):341-6. PubMed ID: 18450442
[TBL] [Abstract][Full Text] [Related]
49. The importance of prognostic factors in premenopausal women with breast cancer.
Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
[TBL] [Abstract][Full Text] [Related]
50. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features.
Boussen H; Bouzaiene H; Ben Hassouna J; Gamoudi A; Benna F; Rahal K
Semin Oncol; 2008 Feb; 35(1):17-24. PubMed ID: 18308142
[TBL] [Abstract][Full Text] [Related]
52. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
53. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Torrisi R; Balduzzi A; Ghisini R; Rocca A; Bottiglieri L; Giovanardi F; Veronesi P; Luini A; Orlando L; Viale G; Goldhirsch A; Colleoni M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):667-72. PubMed ID: 18064460
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease-free survival, mucinous differentiation and response to chemotherapy.
Chen WC; Su PF; Jin YT; Chang MC; Chang TW
Histopathology; 2008 Nov; 53(5):554-60. PubMed ID: 18983464
[TBL] [Abstract][Full Text] [Related]
55. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends.
Boussen H; Bouzaiene H; Ben Hassouna J; Dhiab T; Khomsi F; Benna F; Gamoudi A; Mourali N; Hechiche M; Rahal K; Levine PH
Cancer; 2010 Jun; 116(11 Suppl):2730-5. PubMed ID: 20503401
[TBL] [Abstract][Full Text] [Related]
57. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.
Schairer C; Soliman AS; Omar S; Khaled H; Eissa S; Ayed FB; Khalafallah S; Ayoub WB; Kantor ED; Merajver S; Swain SM; Gail M; Brown LM
Cancer Med; 2013 Apr; 2(2):178-84. PubMed ID: 23634285
[TBL] [Abstract][Full Text] [Related]
58. [Inflammatory breast carcinoma: towards molecular characterization?].
Charafe-Jauffret E; Tarpin C; Ginestier C; Bertucci F; Penault-Llorca F; Xerri L; Birnbaum D; Viens P; Hassoun J; Jacquemier J
Ann Pathol; 2003 Dec; 23(6):564-9. PubMed ID: 15094594
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.
Colpaert CG; Vermeulen PB; Benoy I; Soubry A; van Roy F; van Beest P; Goovaerts G; Dirix LY; van Dam P; Fox SB; Harris AL; van Marck EA
Br J Cancer; 2003 Mar; 88(5):718-25. PubMed ID: 12618881
[TBL] [Abstract][Full Text] [Related]
60. [The history of Tunisian pemphigus].
Kamoun R
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):719-21. PubMed ID: 14576600
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
